ASCO & The Conquer Cancer Foundation announce merit awards

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The Conquer Cancer Foundation of the American Society of Clinical Oncology announced the recipients of its 2019 ASCO Annual Meeting Merit Awards. These awards support oncology trainees who are first authors on abstracts selected for presentation at the ASCO annual meeting.

This year, Conquer Cancer recognized 125 recipients with Merit Awards at the 2019 ASCO Annual Meeting, having already awarded 33 symposia-specific Merit Awards in 2019. These oncology professionals are recognized for their respective field and research advancements within the cancer care community.

The complete list of 2019 ASCO Annual Meeting Merit Award is posted here.

Special Merit Awards are presented each year to trainees and junior faculty who have the top-ranking abstracts for the ASCO Annual Meeting. The ASCO Scientific Program Committee will present five additional recipients with Special Merit Awards in their respective abstract categories:

  • Dai Chihara, NCI at NIH

    • Receives the Bradley Stuart Beller Endowed Merit Award for the highest ranking abstract overall.

    • Supported by Friends and Family of Dr. and Mrs. Ronald Beller.

  • Sarah Abou Alaiwi, Dana-Farber Cancer Institute

    • Receives the Allen S. Lichter, MD, Endowed Merit Award for the second highest ranking abstract overall.

  • Po-Ju Lin, University of Rochester Medical Center

    • Receives the Pain and Symptom Management Special Merit Award for the highest ranked abstract in pain and symptom management research.

  • Adriana Fonseca, The Hospital for Sick Children

    • Receives the Brigid Leventhal Special Merit Award for the top-ranking abstract in pediatric oncology.

    • Supported by The Berry Family.

  • Sumit Gupta, The Hospital for Sick Children

    • Receives the James B. Nachman Endowed ASCO Junior Faculty Award in Pediatric Oncology for the highest scoring abstract in pediatric oncology.

    • Supported by Friends and Family of Dr. James B. Nachman.

Table of Contents

YOU MAY BE INTERESTED IN

Secretary of the U.S. Department of Health and Human Services Robert F. Kennedy Jr. appeared before the House Energy and Commerce Subcommittee on Health to defend the HHS fiscal year 2026 budget proposal, and faced criticism from several Democratic lawmakers on what they described as a lack of transparency and scientific rigor in the agency’s recent decisions.

The full-scale Russian invasion of Ukraine has devastated the Ukrainian healthcare infrastructure, disrupting cancer care, halting clinical trials, and compounding long-standing systemic challenges.  Even before the war, Ukraine’s oncology system faced major constraints: Limited access to radiotherapy equipment, outdated chemotherapy supply chains, and workforce shortages. The invasion intensified these issues—cancer hospitals were damaged, warehouses destroyed,...

Patients affected by cancer are increasingly turning to artificial intelligence-powered chatbots, such as ChatGPT and Gemini, for answers to pressing health questions. These tools, available around the clock and free from geographic or scheduling constraints, are appealing when access to medical professionals is limited by financial, language, logistical, or emotional barriers. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login